Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin

International Journal of Molecular Medicine

Volumn 33, Issue 5, 2014, Pages 1341-1347

  Liu, Jun ^a   Ren, Yingang ^a   Kang, Li ^a   Zhang, Lihua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Matrix metaloproteinase 9; Migration; Osteopontin; Proliferation

Indexed keywords

GELATINASE B; MESSENGER RNA; OSTEOPONTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; VITRONECTIN RECEPTOR; LOW DENSITY LIPOPROTEIN; MMP9 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SMOOTH MUSCLE CELL; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTEGRIN ALPHAVBETA3; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASE 9; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; UP-REGULATION;

EID: 84899512017     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1681     Document Type: Article

References (38)

1. Wang XH, Wang F, You SJ, et al: Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage. Cell Signal 25: 2255-2262, 2013.
2. Glass CK and Witztum JL: Atherosclerosis: the road ahead. Cell 104: 503-516, 2001.
3. González-Navarro H, Abu Nabah YN, Vinué Á, et al: p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J AM Coll Cardiol 55: 2258-2268, 2010.
4. Gerthoffer WT: Mechanisms of vascular smooth muscle cell migration. Circ Res 100: 607-621, 2007.
5. Murry CE, Gipaya CT, Bartosek T, Benditt EP and Schwartz SM: Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 151: 697-705, 1997.
6. Johnson JL, Dwivedi A, Somerville M, George SJ and Newby AC: Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscl Thromb Vas 31: e35-e44, 2011.
7. Li LX, Zhang XF, Bai X and Tong Q: SDF-1 promotes ox-LDL induced vascular smooth muscle cell proliferation. Cell Biol Int 37: 988-994, 2013.
8. Ross R: The pathogenesis of atherosclerosis - an update. New Engl J Med 314: 488-500, 1986.
9. Clarke MC, Figg N, Maguire JJ, et al: Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12: 1075-1080, 2006.
10. Bennett MR and Boyle JJ: Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138: 3-9, 1998.
11. Mazière C, Gomila C and Mazière JC: Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress. Free Radical Bio Med 48: 1382-1387, 2010.
12. Cho HJ, Cho HJ and Kim HS: Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 11: 206-213, 2009.
13. Giachelli CM, Lombardi D, Johnson RJ, Murry CE and Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152: 353-358, 1998.
14. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H and Ashkar S: Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukocyte Biol 72: 752-761, 2002.
15. Koh A, Da Silva AP, Bansal AK, et al: Role of osteopontin in neutrophil function. Immunology 122: 466-475, 2007.
16. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S and Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92: 2814-2820, 1993.
17. Zohar R, Suzuki N, Suzuki K, et al: Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184: 118-130, 2000.
18. Shannon KE, Keene JL, Settle SL, et al: Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247. Clin Exp Metastasis 21: 129-138, 2004.
19. Chen YJ, Wei YY, Chen HT, et al: Osteopontin increases migration and MMP-9 up-regulation via αvβ3 integrin, FAK, ERK, and NF-κB-dependent pathway in human chondrosarcoma cells. J Cell Physiol 221: 98-108, 2009.
20. Newby AC: Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69: 614-624, 2006.
21. Johnson C and Galis ZS: Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscl Thromb Vasc Biol 24: 54-60, 2004.
22. Kuzuya M, Kanda S, Sasaki T, et al: Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 108: 1375-1381, 2003.
23. Johnson JL, George SJ, Newby AC and Jackson CL: Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA 102: 15575-15580, 2005.
24. Belcher J, Egan JO, Bridgman G, Baker R and Flack JM: A micro-enzymatic method to measure cholesterol and triglyceride in lipoprotein subfractions separated by density gradient ultracentrifugation from 200 microliters of plasma or serum. J Lipid Res 32: 359-370, 1991.
25. Feng X, Zhang Y, Xu R, et al: Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis 208: 396-405, 2010.
26. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J biol Chem 193: 265-275, 1951.
27. Shyu KG, Chen SC, Wang BW, Cheng WP and Hung HF: Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells. Clin Sci (Lond) 122: 33-42, 2012.
28. Pellet-Many C, Frankel P, Evans IM, Herzog B, Jünemann-Ramirez M and Zachary IC: Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem J 435: 609-618, 2011.
29. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
30. Aikawa M, Rabkin E, Okada Y, et al: Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97: 2433-2444, 1998.
31. Rangaswami H and Kundu GC: Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol Rep 18: 909-915, 2007.
32. Wai PY and Kuo PC: Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 27: 103-118, 2008.
33. Doran AC, Meller N and McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 812-819, 2008.
34. Lusis AJ: Atherosclerosis. Nature 407: 233-241, 2000.
35. Augé N, Maupas-Schwalm F, Elbaz M, et al: Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110: 571-578, 2004.
36. Ricciarelli R, Zingg JM and Azzi A: Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102: 82-87, 2000.
37. Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R and Negre-Salvayre A: Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscl Thromb Vasc Biol 22: 1990-1995, 2002.
38. Witztum JL and Steinberg D: The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovas Med 11: 93-102, 2001.